Biotech M&A shows signs of life
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Biotechnology companies do two things, in an ideal world: make drugs that improve patient’s lives, and sell themselves — in whole or in part — to Big Pharma. This second element has been difficult to … Read more